| Gregory Charles Dobash, MD | |
|
411 Shenandoah Rd, Ringtown, PA 17967-9432 | |
| (570) 889-3103 | |
| (570) 889-3575 |
| Full Name | Gregory Charles Dobash |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 24 Years |
| Location | 411 Shenandoah Rd, Ringtown, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639110091 | NPI | - | NPPES |
| 001950614 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD420183 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Residential Home Health Of Nc Pa, Llc | Williamsport, PA | Home health agency |
| Geisiner Home Health | Hazleton, PA | Home health agency |
| St Luke's Miners Memorial Hospital | Coaldale, PA | Hospital |
| Geisinger Medical Center | Danville, PA | Hospital |
| Geisinger St. Luke's Hospital | Orwigsburg, PA | Hospital |
| Schuylkill Medical Center - South Jackson Street | Pottsville, PA | Hospital |
| St Luke's Hospital Bethlehem | Bethlehem, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Carbon-schuylkill Community Hospital, Inc. | 4486562030 | 41 |
| St Luke's Physician Group Inc | 6709798333 | 1739 |
News Archive
Today's headlines include continuing coverage about the problems with the healthcare.gov website, how Health and Human Services Secretary Kathleen Sebelius is in the hot seat and how the White House has called in reinforcements - a glitch czar.
A Cochrane review of evidence to date has cast uncertainty over the magnitude of benefit children with attention deficit/hyperactivity gain by taking methylphenidate.
Beyond the tragic surges in hospitalizations and deaths, the first months of the COVID-19 pandemic disrupted healthcare for people with a wide range of medical conditions - including cancer.
Research results published in the Journal of Neurotrauma and conducted by the Walter Reed Army Institute of Research (WRAIR) as part of a collaboration with Concert Pharmaceuticals, Inc. showed that a novel deuterium-containing sigma-1 agonist invented at Concert, called C-10068, demonstrated anti-seizure and anti-inflammatory effects in a preclinical model of traumatic brain injury (TBI).
Scientists at The Scripps Research Institute (TSRI) have discovered the molecular mechanism by which the deadly Ebola virus assembles, providing potential new drug targets.
› Verified 3 days ago
| Entity Name | The Carbon-schuylkill Community Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194891010 PECOS PAC ID: 4486562030 Enrollment ID: O20031117000015 |
News Archive
Today's headlines include continuing coverage about the problems with the healthcare.gov website, how Health and Human Services Secretary Kathleen Sebelius is in the hot seat and how the White House has called in reinforcements - a glitch czar.
A Cochrane review of evidence to date has cast uncertainty over the magnitude of benefit children with attention deficit/hyperactivity gain by taking methylphenidate.
Beyond the tragic surges in hospitalizations and deaths, the first months of the COVID-19 pandemic disrupted healthcare for people with a wide range of medical conditions - including cancer.
Research results published in the Journal of Neurotrauma and conducted by the Walter Reed Army Institute of Research (WRAIR) as part of a collaboration with Concert Pharmaceuticals, Inc. showed that a novel deuterium-containing sigma-1 agonist invented at Concert, called C-10068, demonstrated anti-seizure and anti-inflammatory effects in a preclinical model of traumatic brain injury (TBI).
Scientists at The Scripps Research Institute (TSRI) have discovered the molecular mechanism by which the deadly Ebola virus assembles, providing potential new drug targets.
› Verified 3 days ago
| Entity Name | St Lukes Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700984622 PECOS PAC ID: 6709798333 Enrollment ID: O20040226000062 |
News Archive
Today's headlines include continuing coverage about the problems with the healthcare.gov website, how Health and Human Services Secretary Kathleen Sebelius is in the hot seat and how the White House has called in reinforcements - a glitch czar.
A Cochrane review of evidence to date has cast uncertainty over the magnitude of benefit children with attention deficit/hyperactivity gain by taking methylphenidate.
Beyond the tragic surges in hospitalizations and deaths, the first months of the COVID-19 pandemic disrupted healthcare for people with a wide range of medical conditions - including cancer.
Research results published in the Journal of Neurotrauma and conducted by the Walter Reed Army Institute of Research (WRAIR) as part of a collaboration with Concert Pharmaceuticals, Inc. showed that a novel deuterium-containing sigma-1 agonist invented at Concert, called C-10068, demonstrated anti-seizure and anti-inflammatory effects in a preclinical model of traumatic brain injury (TBI).
Scientists at The Scripps Research Institute (TSRI) have discovered the molecular mechanism by which the deadly Ebola virus assembles, providing potential new drug targets.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gregory Charles Dobash, MD 411 Shenandoah Rd, Ringtown, PA 17967-9432 Ph: (570) 889-3103 | Gregory Charles Dobash, MD 411 Shenandoah Rd, Ringtown, PA 17967-9432 Ph: (570) 889-3103 |
News Archive
Today's headlines include continuing coverage about the problems with the healthcare.gov website, how Health and Human Services Secretary Kathleen Sebelius is in the hot seat and how the White House has called in reinforcements - a glitch czar.
A Cochrane review of evidence to date has cast uncertainty over the magnitude of benefit children with attention deficit/hyperactivity gain by taking methylphenidate.
Beyond the tragic surges in hospitalizations and deaths, the first months of the COVID-19 pandemic disrupted healthcare for people with a wide range of medical conditions - including cancer.
Research results published in the Journal of Neurotrauma and conducted by the Walter Reed Army Institute of Research (WRAIR) as part of a collaboration with Concert Pharmaceuticals, Inc. showed that a novel deuterium-containing sigma-1 agonist invented at Concert, called C-10068, demonstrated anti-seizure and anti-inflammatory effects in a preclinical model of traumatic brain injury (TBI).
Scientists at The Scripps Research Institute (TSRI) have discovered the molecular mechanism by which the deadly Ebola virus assembles, providing potential new drug targets.
› Verified 3 days ago